Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ValbiotisPRO Cardio-Circulation is a plant-derived nutraceutical developed by Valbiotis in partnership with Nestlé Health Science. It is a proprietary botanical blend, specifically derived from the TOTUM-070 active compound, designed to support cardiovascular health. The formulation targets issues such as high blood pressure (hypertension) and poor circulation symptoms like heavy legs and tingling. It consists of a 100% natural blend of six plant extracts, including olive, artichoke, garlic, bilberry, chrysanthellum, and black pepper. The product's efficacy was validated in clinical studies, such as the HEART study, and it was commercially launched in France in June 2025.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ValbiotisPRO Cardio-Circulation.